Eosinophilic Disorders Patients | 合法藥品大搜索

由 S Hanon 著作 · 2020 · 被引用 17 次 — In a cohort of severe asthma patients, a small number of COVID-19 cases was ... in Belgium are omalizumab, mepolizumab, benralizumab and reslizumab, while​ ... Read More

由 K Eger 著作 · 2021 · 被引用 13 次 — ... and disease course of COVID-19 in patients with severe asthma on biologic therapy (omalizumab, mepolizumab, reslizumab, benralizumab, ... Read More

COVID-19: Advice, updates and vaccine options ... Reslizumab (Intravenous Route) ... Reslizumab injection is used with other medicines for the maintenance​ ... Read More

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With ... Read More

由 K Eger 著作 · 被引用 13 次 — ... severe course of COVID-19 compared to the general population. ... reslizumab, benralizumab, dupilumab), as compared with COVID-19 data ... Read More

2021年1月4日 — ... and disease course of COVID-19 in patients with severe asthma on biologic therapy (omalizumab, mepolizumab, reslizumab, benralizumab, ... Read More

由 AT Akenroye 著作 · 2020 · 被引用 17 次 — ... of COVID-19 may differ. Omalizumab (an anti–immunoglobulin E [IgE] antibody​), mepolizumab and reslizumab (which block interleukin [IL] 5) ... Read More

由 D Pala 著作 · 2021 — In severe COVID-19 patients, the blockade of eosinophils' activation might ... Anti-​IL-5 drugs (benralizumab, mepolizumab, reslizumab) are ... Read More

Patients on eosinophil-depleting drugs, such as benralizumab, mepolizumab, and reslizumab, as well as patients on dupilumab, have not been reported to have ... Read More

Reslizumab (Cinqair). OFFICE ADMININSTRATION. Indications for Prior Authorization: Severe Eosinophilic Asthma. All of the following must be met as a ... Read More